Patient-Focused Drug Development
Inspire's PFDD solution helps our clients answer the FDA's call for valuable perspectives from patients, family members, and caregivers throughout drug development​
The FDA has made increasing commitments to the inclusion of Patient Focused Drug Development (PFDD) and Real World Evidence (RWE). FDA is working on guidances around PFDD for the pharmaceutical industry, focused on incorporating the patient voice and perspectives into key components of its regulatory decision process.
Inspire’s experience with FDA has driven and defined our PFDD solutions, founded in real world patient and caregiver voice.
Robust solution with great flexibility and scalability
Throughout the trial and product life cycle, Inspire Insights products access meaningful real world evidence (RWE) about patient experiences, perspectives, needs and priorities for systematic consolidation into drug development.
We utilize our broad range of Inspire member engagement methods and advanced primary and secondary data analytics capabilities to design and conduct research that develops structured patient experience data and that delivers actionable results.
Whether you are a small team focusing on just one study or a large pharma team needing help across an entire portfolio, you can count on our team and platform to support you.
Inspire PFDD experts are here to help you in every step of the process.
Inspire’s dedicated research team consisting of sociolinguists, qualitative and quantitative research specialists who have worked on hundreds of research projects engaging with patients and caregivers as well as the engagement technology platform your team needs to infuse the patient voice in drug and medical product development.
Top reasons why customers choose Inspire to be their PFDD partner
- Input from nearly 2M engaged, authentic, and non-professional patients and caregivers, representing over 3,600 conditions
- Methodologies incorporate scientifically repeatable Patient Reported Outcomes (PRO) and RWE measurement
- Multiple and highly customizable research methods and RWE patient data sets to support PFDD initiatives
- Delivery of raw data to support reporting and other submission documents (as required by FDA)
- Ongoing consultation from Inspire’s patient-focused research experts
- Fast delivery - in weeks, not months - that includes advanced analysis with actionable recommendations in each deliverable
How does PFDD at Inspire work?
PFDD consulting at any step throughout the Drug Development Process
STEP 1
Discover & Preclinical Studies
Patient Unmet Needs
Patient perspective on protocol design and development
STEP 2
Clinical Trials
Patient Information on barriers to enrollment and retention
Patient perspective on cost, obtaining knowledge base, marketing materials, insert understanding
STEP 3
FDA Review/Approval
STEP 4
Post Marketing
Surveillance
Patient experience with medication/ side effects
Engage Surveys
Pulse surveys
Engage Virtual Patient Interviews
Virtual Patient Interviews
Discover
Social landscape
In-depth surveys
Virtual Advisory Boards
Strategic Deep Dive
Capabilities to achieve PFDD
How we obtain RWE for our customers
FDA is committed to inclusion of Patient Focused Drug Development over many disease areas.
Find the specific patient population you need, all in one platform
